The second cluster was significantly associated with several tumor signaling pathways, such as the PI3K-Akt signaling pathway, EGFR tyrosine kinase inhibitor resistance pathway, Ras signaling pathway, and MAPK signaling pathway. The gene discussed is EGFR; the disease is neoplasm.